News
2021
U/A 7+
🅿 #SerumInstitute #COVIDVaccine #Covavax Centre's panel has recommended against allowing Serum Institute of India to conduct phase two and three clinical trials of Covavax Covid-19 vaccine on children in 2-17 years age group, ANI quoted sources as saying. Centre's panel has recommended against allowing Serum Institute of India to conduct phase two and three clinical trials of Covavax Covid-19 vaccine on children in 2-17 years age group, ANI quoted sources as saying.Show more